ArticleRheumatology and therapy2025

Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.

Peter Youssef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.